My TransOvaLog In
Apr 15, 2024
Trans Ova Genetics Appoints New CEO to Lead Next Phase of Growth
Sioux Center, Iowa, April 15, 2024 – Trans Ova Genetics, the leading advanced reproductive technologies company, announced the appointment of Kevin Hoogendoorn, DVM, as its new Chief Executive Officer. Hoogendoorn succeeds Dr. David Faber, the founder of the company, who has been at the helm since its inception.
In his new role, Hoogendoorn will be responsible for driving Trans Ova Genetics’ strategic vision and leading the company through its next phase of growth. With a proven track record of innovation, strategy, and leadership in ag business, Hoogendoorn brings a wealth of knowledge and expertise to Trans Ova Genetics.
Dr. Faber, who will transition into a role that supports the transition of Hoogendoorn within Trans Ova, along with responsibilities within URUS, expressed his confidence in Hoogendoorn and the future of Trans Ova Genetics. “I am thrilled to welcome Dr Hoogendoorn as the new CEO of Trans Ova Genetics. His strong leadership skills and strategic vision make him a great choice to lead the company forward. I look forward to supporting him in this transition and continuing to contribute to the company’s success.”
Hoogendoorn commented on his appointment, stating, “I am honored to join Trans Ova Genetics as its new CEO. I am excited about the opportunity to work with the talented team at Trans Ova and build upon the strong foundation established Dr. Faber. Together, we will continue to innovate and drive growth, delivering value to our clients and stakeholders.”
With 23 years of experience as a dairy veterinarian/nutritionist, 12 years as General Manager of a dairy feed company, and 9 years leading a private dairy consulting firm, Dr. Kevin Hoogendoorn is a seasoned professional in the agricultural industry. His strategic thinking, coupled with his business acumen, has led to significant revenue growth and the establishment of successful ventures. His appointment reflects Trans Ova Genetics’ commitment to excellence and its dedication to delivering exceptional results.
For more information on the new location of Trans Ova Genetics, or to schedule procedures, please contact Trans Ova Genetics headquarters at 800-999-3586. For more information on Trans Ova Genetics, or more information on reproductive programs that add value to your breeding operation, please visit www.transova.com.
Founded in 1980, Trans Ova Genetics offers advanced reproductive technologies to help breeders multiply the success of their elite cattle. These technologies include embryo transfer, in vitro fertilization, sex-sorted semen, recipient options, as well as genetic preservation and cloning services. Headquartered in Sioux Center, Iowa, Trans Ova Genetics has regional centers in Missouri, Maryland, Texas, Oklahoma, South Dakota, California, Washington, Wisconsin, Georgia, and Idaho as well as multiple satellite locations throughout the United States.
###
For media inquiries, please contact:
Sara Kober • Director of Marketing
260-287-0632
Sara.Kober@transova.com